Salmeterol Ticarcoson Powder Inhaler can be discontinued under doctor’s supervision if the control of the disease is stable, if the control is not stable, the drug should not be discontinued, so as not to cause recurrence or aggravation of the disease. Salmeterol ticarcoson powder inhaler is a compound drug, mainly used for the treatment of obstructive airway diseases, such as asthma, chronic obstructive pulmonary disease, can relieve shortness of breath, wheezing and other symptoms, the drug belongs to the inhaled corticosteroid. If the control of the disease is stabilized with the use of this drug, then the drug can be reasonably discontinued under the guidance of the doctor. If the control of the disease is not stable, suddenly stopping the drug can cause recurrence and aggravation of the disease and other adverse consequences. Common adverse reactions and contraindications of the drug include palpitations (rapid heartbeat, often accompanied by panic), headache, abnormal bronchial spasm, etc.; allergy to the drug is prohibited. The use of the drug and discontinuation of the drug should be under the guidance of a doctor to use and appropriate discontinuation, not unauthorized increase or decrease in dosage or discontinuation of the drug, in order to avoid causing adverse effects.